–
Статьи в журналах
-
- 2024 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
- Oh Do-Youn, He Aiwu Ruth, Bouattour Mohamed, Okusaka Takuji, Qin Shukui, Chen Li-Tzong, Kitano Masayuki, Lee Choong-kun, Kim Jin Won, Chen Ming-Huang, Suksombooncharoen Thatthan, Ikeda Masafumi, Lee Myung Ah, Chen Jen-Shi, Potemski Piotr, Burris Howard A., Ostwal Vikas, Tanasanvimon Suebpong, Morizane Chigusa, Zaucha Renata E., McNamara Mairéad G., Avallone Antonio, Cundom Juan E., Breder Valeriy, Tan Benjamin, Shimizu Satoshi, Tougeron David, Evesque Ludovic, Petrova Mila, Zhen David B., Gillmore Roopinder, Gupta Vineet Govinda, Dayyani Farshid, Park Joon Oh, Buchschacher Gary L., Rey Felipe, Kim Hyosung, Wang Julie, Morgan Claire, Rokutanda Nana, Żotkiewicz Magdalena, Vogel Arndt, Valle Juan W.
- в журнале The Lancet Gastroenterology & Hepatology, издательство Elsevier (United States), том 9, № 8, с. 694-704 DOI